Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines

• Published in: Experimental eye research 2009-08, Vol.89 (2), p.200-208
• Main Authors: Mikami-Terao, Yoko, Akiyama, Masaharu, Yuza, Yuki, Yanagisawa, Takaaki, Yamada, Osamu, Kawano, Takeshi, Agawa, Miyuki, Ida, Hiroyuki, Yamada, Hisashi
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - metabolism; Antineoplastic Agents - pharmacology; apoptosis; Apoptosis - drug effects; Apoptosis - radiation effects; Cell Division - drug effects; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors - pharmacology; G-quadruplex; G-Quadruplexes - drug effects; histone H2AX; Histones - metabolism; Humans; irradiation; Mitogen-Activated Protein Kinase Kinases - metabolism; Phosphorylation - drug effects; Porphyrins - metabolism; Porphyrins - pharmacology; Retinal Neoplasms - genetics; Retinal Neoplasms - metabolism; Retinal Neoplasms - pathology; retinoblastoma; Retinoblastoma - genetics; Retinoblastoma - metabolism; Retinoblastoma - pathology; Telomerase - antagonists & inhibitors; Tumor Cells, Cultured
• ISSN: 0014-4835; 1096-0007
• DOI: 10.1016/j.exer.2009.03.008

To investigate the molecular mechanism of the antitumor activity of the cationic porphyrin 5, 10, 15, 20-tetra-( N-methyl-4-pyridyl)porphyrin (TMPyP4) in retinoblastoma cell lines, Y79 and WERI-Rb1 cells were treated with TMPyP4 for 0–72 h, after which growth inhibition, modulation of the cell cycle and the induction of apoptosis were examined. In addition, the effect of TMPyP4 on the susceptibility to irradiation was evaluated in Y79 and WERI-Rb1 cells. In vitro telomeric repeat amplification protocol assay showed TMPyP4 (10–100 μM) directly blocked telomerase elongation, suggesting that TMPyP4 can form stable guanine (G)-quadruplexes in extending telomere repeats in substrate oligonucleotides. The antiproliferative activities of TMPyP4 assessed with the MTS assay and expressed in terms of IC 50: Y79 cells, 60 μM; WERI-Rb1 cells, 45 μM. Treatment with TMPyP4 at doses of 10, 20, 50 or 100 μM for 48 or 72 h significantly inhibited the growth of Y79 and WERI-Rb1 cells. Apoptosis, as assessed with CaspACE™ FITC-VAD-FMK, was induced by TMPyP4 in a dose-dependent manner. Induction of apoptosis by TMPyP4 was associated with increased expression of phosphorylated DNA damage response factor H2AX (Ser139), phosphorylated p53 (Ser46) protein and activation of mitogen-activated protein kinases in Y79 and WERI-Rb1 cells. Moreover, TMPyP4 significantly enhanced the susceptibility to irradiation in both cell lines. This study provides insight into the molecular mechanism of the antitumor effects of TMPyP4. G-quadruplex structure may be a potential therapeutic target in retinoblastoma.